SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-09-028701
Filing Date
2009-05-20
Accepted
2009-05-20 17:08:56
Documents
5
Period of Report
2009-06-18
Effectiveness Date
2009-05-20

Document Format Files

Seq Description Document Type Size
1 v149083_def14a.htm DEF 14A 2795627
2 GRAPHIC logo_sunesis-smlblack.jpg GRAPHIC 6140
3 GRAPHIC sig_ebjerkholt.jpg GRAPHIC 6510
4 GRAPHIC v148535_proxycardx1x1.jpg GRAPHIC 351827
5 GRAPHIC v148535_proxycardx2x1.jpg GRAPHIC 91638
  Complete submission text file 0001144204-09-028701.txt   3426307
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51531 | Film No.: 09843324
SIC: 2834 Pharmaceutical Preparations